German genetic-test specialist Qiagen beat forecasts with its third-quarter results and slightly upped its full-year outlook Tuesday. "We're...
Flu vaccines were once a business that many drug companies avoided, but that segment of the pharma industry is now firmly in the spotlight. ...
A pharma insider gives an outlook for the sector, with Brian Markison, King Pharmaceuticals CEO.
The reflation trade is likely to continue in the near term, believes Lim Say Boon, chief investment strategist from Standard Chartered Group...
Cramer takes a look at some companies that are making major strides in treating cancer.
Vertex Pharmaceuticals unveiled more positive results on the drug its developing with Johnson & Johnson to treat Hepatitis C. CNBC's Mike Hu...
The FDA has approved Amylin's Byetta as a stand-alone diabetes drug. The company's CEO, Daniel Bradbury, discusses the approval and more wit...
Dendreon has completed its FDA submission for prostate cancer drug Provenge, reports CNBC's Mike Huckman.
Manufacturers are having issues with yields from strains used to produce H1N1 vaccines, says Rhenu Bhuller, global VP of pharmaceuticals at ...
Sanofi sees Q4 H1N1 vacccine sales of around $500 million, with Chris Viehbacher, Sanofi-Aventis CEO and CNBC's Mike Huckman.
The FDA is giving emergency use authorization for BioCryst flu drug, with Jon Stonehouse, BioCryst Pharmaceuticals CEO and CNBC's Mike Huckm...
Novo Nordisk's shares fell sharply Thursday despite the insulin-maker reporting better-than-expected third-quarter earnings and raising its ...
Posts |
TOPIC : Pharmaceuticals
When I went to the FDA's Web site today I was surprised to see on the homepage a link to a letter written by Commissioner Dr... Read More
10 Nov 2009
Many analysts, lobbyists and industry executives have been saying for months that healthcare reform would probably end up being a net positive for the drug companies... Read More
6 Nov 2009
Stacy and Clinton definitely had nothing to do with it, but Sanofi-Pasteur (the vaccines division of Sanofi-Aventis) greets visitors with a "What Not To Wear" brochure... Read More
4 Nov 2009
I am not a Trekkie... Read More
3 Nov 2009
Pfizer, or one of its ad agencies, is apparently putting out a casting call for a new Lipitor pitchman.... Read More
News |
TOPIC : Pharmaceuticals
Thursday, 5 Nov 2009
Source: CNBC staff and wire reports
Tuesday, 3 Nov 2009
Tuesday, 3 Nov 2009
Friday, 30 Oct 2009
Friday, 23 Oct 2009
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
